Nominating Committee. For so long as Amneal Group has beneficial ownership of more than fifty percent (50%) of the outstanding shares of Company Common Stock, (i) the Nominating Committee shall consist of four (4) directors; (ii) the Amneal Group Representative shall have the right to designate two (2) of the directors to serve on the Nominating Committee; and (iii) the remaining directors on the Nominating Committee shall be designated by a majority of the Company Independent Directors then serving on the Company Board.
Appears in 5 contracts
Samples: Stockholders Agreement (Amneal Pharmaceuticals, Inc.), Stockholders Agreement (Atlas Holdings, Inc.), Business Combination Agreement (Impax Laboratories Inc)
